Domestic pharmaceutical firms stingy on R&D

Published: 2006-11-01 07:00:00

Updated: 2006-11-01 07:00:00

Korean pharmaceutical companies are spending little money on research and development (R&D) activities as they focus more on marketing and advertisement outlays, a lawmaker said recently citing government statistics.

Rep. Ahn Myung-Ok of the opposition Grand National Party said R&D spending of 55 local firms listed in Korean Stock Exchange stood at 338.7 billion won on R&D activities in ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.